Published in Arch Neurol on April 01, 2010
The effect of basal vasodilation on hypercapnic and hypocapnic reactivity measured using magnetic resonance imaging. J Cereb Blood Flow Metab (2010) 0.95
Multimodal MRI characterization of experimental subarachnoid hemorrhage. Neuroscience (2015) 0.84
CO2 has no therapeutic effect on early microvasospasm after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab (2014) 0.82
Chronic central nervous system expression of HIV-1 Tat leads to accelerated rarefaction of neocortical capillaries and loss of red blood cell velocity heterogeneity. Microcirculation (2014) 0.76
Temporal Profiles of Cerebral Perfusion Pressure After Subarachnoid Hemorrhage. J Neurosci Nurs (2015) 0.75
A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97
Bioethical considerations in translational research: primate stroke. Am J Bioeth (2009) 7.21
Guidelines for the evaluation and management of status epilepticus. Neurocrit Care (2012) 5.00
Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology (2007) 4.22
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol (2010) 3.49
Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke (2002) 3.36
Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol (2002) 3.36
National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Ann Intern Med (2010) 3.24
Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med (2004) 3.24
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol (2011) 3.08
Continuous electroencephalography in the medical intensive care unit. Crit Care Med (2009) 2.86
Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke (2011) 2.81
Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care (2011) 2.81
Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med (2006) 2.58
Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery (2009) 2.58
Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med (2008) 2.57
Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke (2005) 2.49
Current status of endovascular stroke treatment. Circulation (2011) 2.42
Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke (2005) 2.36
Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity (2006) 2.36
Neuropsychological dysfunction in the absence of structural evidence for cerebral ischemia after uncomplicated carotid endarterectomy. Neurosurgery (2006) 2.33
Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke (2009) 2.28
ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci (2002) 2.25
NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline. NIH Consens State Sci Statements (2010) 2.19
External ventricular drainage following aneurysmal subarachnoid haemorrhage. Br J Neurosurg (2010) 2.15
Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia (2002) 2.14
Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke (2002) 2.13
Intracranial infectious aneurysms: a comprehensive review. Neurosurg Rev (2009) 2.11
Frequency and predictors of nonconvulsive seizures during continuous electroencephalographic monitoring in critically ill children. Arch Neurol (2006) 2.05
Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med (2007) 1.97
A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol (2002) 1.91
Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90
Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care (2006) 1.89
Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation (2005) 1.88
Inter-individual variability in the capacity for motor recovery after ischemic stroke. Neurorehabil Neural Repair (2007) 1.86
Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch Neurol (2011) 1.85
Ventriculostomy-related infections: a critical review of the literature. Neurosurgery (2002) 1.84
Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest (2002) 1.80
Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke (2003) 1.78
Carotid-cavernous fistulas. Neurosurg Focus (2012) 1.76
Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med (2004) 1.76
Reemergence of stroke deficits with midazolam challenge. Stroke (2002) 1.73
Improvement in aphasia scores after stroke is well predicted by initial severity. Stroke (2010) 1.72
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery (2006) 1.68
Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc (2007) 1.66
Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery (2006) 1.65
Metabolic benefits of surface counter warming during therapeutic temperature modulation. Crit Care Med (2009) 1.64
Generalized periodic discharges in the critically ill: a case-control study of 200 patients. Neurology (2012) 1.64
Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res (2006) 1.63
Fever after subarachnoid hemorrhage: risk factors and impact on outcome. Neurology (2007) 1.61
Initial misdiagnosis and outcome after subarachnoid hemorrhage. JAMA (2004) 1.58
Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage. Clin Neurophysiol (2004) 1.55
Treatment guidelines for cerebral arteriovenous malformation microsurgery. Br J Neurosurg (2009) 1.54
The surgical management of chronic subdural hematoma. Neurosurg Rev (2011) 1.54
Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes. World Neurosurg (2012) 1.53
Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery (2005) 1.51
Continuous electroencephalographic monitoring in critically ill patients with central nervous system infections. Arch Neurol (2008) 1.51
Predictors of neurocognitive decline after carotid endarterectomy. Neurosurgery (2006) 1.49
Convulsive status epilepticus after ischemic stroke and intracerebral hemorrhage: frequency, predictors, and impact on outcome in a large administrative dataset. Neurocrit Care (2007) 1.49
Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. Blood (2009) 1.48